The study investigates the safety and efficacy of PMX-60056 for the Reversal of Heparin in
Patients Undergoing Percutaneous Coronary Intervention (PCI)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01312935
Ages eligible for Study
18 Years to 80 Years
Genders eligible for Study
Accepts Healthy Volunteers
The patient will undergo PCI for diagnostic and/or therapeutic purposes with a procedure that uses anticoagulation before the instrumentation and reversal of anticoagulation immediately after the procedure.
Male or female patients of any race, aged 18-80 years old.
The patient will be anti-coagulated with unfractionated heparin.
The patient is medically stable and physically and mentally able to participate in this study.
The patient has given written informed consent to participate in this study after fully understanding the implications and constraints of the protocol.
The patient requires emergency surgery under conditions which prevent compliance with this protocol or which might cause unacceptable risk to the patient.
The patient requires any concomitant surgical procedures (e.g., carotid artery, CABG) during the PCI.
The patient has received any investigational drug within 30 days of study enrollment, or has had any prior exposure to PMX-60056.
The patient has any condition or abnormality which may, in the opinion of the Investigator, compromise the safety of the patient.
The patient is pregnant or breast feeding.
The patient is of childbearing potential and not under adequate contraceptive protection.
The patient has a history of clinically significant hematologic disease including heparin-induced thrombocytopenia, bleeding disorders, or platelet count <100,000.
Severe impaired hepatic function (SGOT, SGPT >2 x ULN).
History of AIDS, ± HIV.
History of allergy to heparin (beef or pig), protamine, or salmon.
History of chronic alcohol or drug abuse within the last one year.
All locations for NCT01312935
United States (3)
South Bend, Indiana, United States
Detroit, Michigan, United States
Rapid City, South Dakota, United States
View full eligibility
Tris trial is registered with FDA with number: NCT01312935. The sponsor of the trial is PolyMedix, Inc. and it is looking for 17 volunteers for the current phase.
Official trial title: A Phase 2 Proof of Concept Study of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.